RNA 分析/转录组学市场：按产品、技术、应用和最终用户划分 - 2025-2030 年全球预测

2023年RNA分析/转录组学市场规模为53.7亿美元，预计2024年将达到59.2亿美元，复合年增长率为10.49%，2030年将达到107.9亿美元。

RNA 分析，特别是转录组学，在理解复杂基因表现和功能方面发挥关键作用，使其成为基因组研究和个人化医疗的重要工具。其范围包括定序和表达分析，以研究 mRNA、tRNA 和 rRNA 等 RNA 转录物。这种需求源自于对精准医学、药物发现和生物标记辨识的需求。应用范围涵盖癌症研究、神经生物学和感染疾病，了解 RNA 可以揭示疾病机制和治疗标靶。最终用途领域包括学术研究、製药、生技公司和诊断实验室。关键的成长要素包括次世代定序(NGS) 技术的进步、基因组学计划资金的增加以及对基于 RNA 的治疗方法日益浓厚的兴趣。机会存在于开发具有成本效益的高通量RNA测序平台以及用于资料分析、简化工作流程和发现基因调控新见解的生物资讯工具的进步中。然而，RNA资料解释的复杂性、资料储存和管理问题以及RNA测序技术的高成本等挑战可能会阻碍市场成长。迫切需要技术创新来支援可扩展性和广泛采用，例如自动化分析过程和提高 RNA资料库的准确性和可访问性。市场呈现出充满活力的景象，单细胞 RNA 定序和即时定量 PCR 的创新前景广阔，为进入农业基因组学和环境监测等开拓领域提供了途径。为了业务成长，企业需要专注于与学术机构合作，推动联合研究，利用人工智慧提高分析能力。儘管市场竞争激烈，但在持续的技术进步和 RNA 分析在临床环境中的整合度不断提高的推动下，预计该市场将迅速扩大，并将其定位为未来基因组研究和诊断的基石。

市场动态：揭示快速发展的 RNA 分析/转录组学市场的关键市场洞察

RNA 分析/转录组学市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

• 市场驱动因素
  • 与 DNA 相比，更倾向于 RNA 分析，导致 RNA 转录组学应用的成长
  • 对个人化医疗和标靶治疗的需求不断增长
  • 增加製药和生物技术研发支出以及政府对体学的资助
• 市场限制因素
  • 高研发成本与资料管理问题
• 市场机会
  • 越来越多地关註生物标誌物
  • 尖端RNAi疗法的开发
• 市场挑战
  • 缺乏有效的生物资讯学工具

波特五力：驾驭 RNA 分析/转录组学市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 RNA 分析/转录组学市场的外部影响

外部宏观环境因素在塑造 RNA 分析/转录组学市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解 RNA 分析/转录组学市场的竞争格局

RNA 分析/转录组学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵RNA分析/转录组学市场供应商绩效评估

FPNV定位矩阵是评估RNA分析/转录组市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议为 RNA 分析/转录组学市场的成功指明了道路

RNA 分析/转录组学市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • RNA 分析的趋势高于 DNA 导致 RNA 转录组学应用的成长
    • 对个人化医疗和标靶治疗的需求不断增长
    • 製药和生物技术研发支出以及政府对体学的资助不断增加
  • 抑制因素
    • 高研发成本与资料管理问题
  • 机会
    • 越来越多地关註生物标誌物
    • 尖端RNAi疗法的开发
  • 任务
    • 缺乏有效的生物资讯学工具
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章 RNA 分析/转录组学市场：副产品

• 装置
• 试剂或耗材
• 服务
• 软体

第 7 章 RNA 分析/转录组学市场：依技术分类

• 微阵列
• 聚合酵素链锁反应
• RNA干扰
• 定序

第 8 章 RNA 分析/转录组学市场：依应用分类

• 临床诊断
• 比较转录组学
• 药物发现
• 毒理基因组学

第 9 章 RNA 分析/转录组学市场：依最终使用者分类

• 学术研究所
• 合约调查机构
• 医院
• 製药和生物技术公司

第10章美洲RNA分析/转录组学市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第十一章亚太RNA分析/转录组市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十二章欧洲、中东和非洲的RNA分析/转录组市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十三章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• Acobiom
• Affymetrix, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• CD Genomics
• Cenix BioScience GmbH
• Danaher Corporation
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Fluidigm Corporation
• GenXPro GmbH
• Illumina, Inc.
• Lexogen GmbH
• Merck KGaA
• Pacific Bioscience of California, Inc.
• Promega Corporation
• QIAGEN NV
• Sequentia Biotech SL
• Thermo Fisher Scientific, Inc.

The RNA Analysis/Transcriptomics Market was valued at USD 5.37 billion in 2023, expected to reach USD 5.92 billion in 2024, and is projected to grow at a CAGR of 10.49%, to USD 10.79 billion by 2030.

RNA analysis, particularly transcriptomics, plays a critical role in understanding the complexities of gene expression and function, making it an indispensable tool in genomic research and personalized medicine. The scope includes sequencing and expression analysis to investigate RNA transcripts like mRNA, tRNA, and rRNA. Its necessity stems from the demand for precision medicine, drug discovery, and biomarker identification. Applications span across cancer research, neurobiology, and infectious diseases, where understanding RNA can illuminate disease mechanisms and therapeutic targets. End-use sectors encompass academic research, pharmaceuticals, biotechnology firms, and diagnostic laboratories. Key growth factors include advancements in next-generation sequencing (NGS) technologies, increased funding for genomics projects, and growing interest in RNA-based therapies. Opportunities lie in developing cost-effective and high-throughput RNA sequencing platforms, as well as advancing bioinformatics tools for data analysis, which can streamline workflows and uncover novel insights into gene regulation. However, challenges such as the complexity of RNA data interpretation, issues with data storage and management, and the high cost of RNA sequencing technologies can hinder market growth. There's an imperative for innovation in automating analysis processes and improving the accuracy and accessibility of RNA databases to support scalability and broader adoption. The market exhibits a dynamic landscape with promising innovations in single-cell RNA sequencing and real-time quantitative PCR, offering avenues to penetrate untapped segments such as agricultural genomics and environmental monitoring. For business growth, companies should focus on partnerships with academic institutions to drive research collaborations and leverage artificial intelligence to enhance analytical capabilities. The nature of the market is competitive yet poised for rapid expansion, driven by sustained technological advancements and the growing integration of RNA analysis in clinical settings, positioning it as a cornerstone in the future of genomic research and diagnostics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving RNA Analysis/Transcriptomics Market

The RNA Analysis/Transcriptomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High Inclination Toward RNA Analysis Over DNA Leading to Growth in RNA Transcriptomics Applications
  • Rising Demand for Personalized Medicine and Targeted Therapeutics
  • Growing Pharmaceutical and Biotechnology R&D Expenditure and Government Funding for Omics
• Market Restraints
  • Expensive R&D and Issues Related to Data Management
• Market Opportunities
  • Increasing Focus on Biomarker
  • State-of-the-art RNAi Therapies In Development
• Market Challenges
  • Lack of Effective Bioinformatics Tools

Porter's Five Forces: A Strategic Tool for Navigating the RNA Analysis/Transcriptomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the RNA Analysis/Transcriptomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the RNA Analysis/Transcriptomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the RNA Analysis/Transcriptomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the RNA Analysis/Transcriptomics Market

A detailed market share analysis in the RNA Analysis/Transcriptomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the RNA Analysis/Transcriptomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the RNA Analysis/Transcriptomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the RNA Analysis/Transcriptomics Market

A strategic analysis of the RNA Analysis/Transcriptomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the RNA Analysis/Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include Acobiom, Affymetrix, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., CD Genomics, Cenix BioScience GmbH, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, GenXPro GmbH, Illumina, Inc., Lexogen GmbH, Merck KGaA, Pacific Bioscience of California, Inc., Promega Corporation, QIAGEN N.V., Sequentia Biotech SL, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the RNA Analysis/Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instruments, Reagents or Consumables, Services, and Software.
• Based on Technology, market is studied across Microarrays, Polymerase Chain Reaction, RNA Interference, and Sequencing.
• Based on Application, market is studied across Clinical Diagnostics, Comparative Transcriptomics, Drug Discovery, and Toxicogenomics.
• Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High Inclination Toward RNA Analysis Over DNA Leading to Growth in RNA Transcriptomics Applications
    • 5.1.1.2. Rising Demand for Personalized Medicine and Targeted Therapeutics
    • 5.1.1.3. Growing Pharmaceutical and Biotechnology R&D Expenditure and Government Funding for Omics
  • 5.1.2. Restraints
    • 5.1.2.1. Expensive R&D and Issues Related to Data Management
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing Focus on Biomarker
    • 5.1.3.2. State-of-the-art RNAi Therapies In Development
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of Effective Bioinformatics Tools
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. RNA Analysis/Transcriptomics Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents or Consumables
• 6.4. Services
• 6.5. Software

7. RNA Analysis/Transcriptomics Market, by Technology

• 7.1. Introduction
• 7.2. Microarrays
• 7.3. Polymerase Chain Reaction
• 7.4. RNA Interference
• 7.5. Sequencing

8. RNA Analysis/Transcriptomics Market, by Application

• 8.1. Introduction
• 8.2. Clinical Diagnostics
• 8.3. Comparative Transcriptomics
• 8.4. Drug Discovery
• 8.5. Toxicogenomics

9. RNA Analysis/Transcriptomics Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Contract Research Organizations
• 9.4. Hospitals
• 9.5. Pharmaceutical & Biotechnology Companies

10. Americas RNA Analysis/Transcriptomics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific RNA Analysis/Transcriptomics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa RNA Analysis/Transcriptomics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acobiom
• 2. Affymetrix, Inc.
• 3. Agilent Technologies, Inc.
• 4. Bio-Rad Laboratories, Inc.
• 5. CD Genomics
• 6. Cenix BioScience GmbH
• 7. Danaher Corporation
• 8. Eurofins Scientific
• 9. F. Hoffmann-La Roche Ltd.
• 10. Fluidigm Corporation
• 11. GenXPro GmbH
• 12. Illumina, Inc.
• 13. Lexogen GmbH
• 14. Merck KGaA
• 15. Pacific Bioscience of California, Inc.
• 16. Promega Corporation
• 17. QIAGEN N.V.
• 18. Sequentia Biotech SL
• 19. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. RNA ANALYSIS/TRANSCRIPTOMICS MARKET RESEARCH PROCESS
• FIGURE 2. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. RNA ANALYSIS/TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. RNA ANALYSIS/TRANSCRIPTOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS OR CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COMPARATIVE TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TOXICOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. CHINA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. ITALY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. POLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. POLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. POLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. POLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. QATAR RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM RNA ANALYSIS/TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. RNA ANALYSIS/TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. RNA ANALYSIS/TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023